Acute antidepressant effects of intramuscular versus intravenous ketamine

Acute antidepressant effects of intramuscular versus intravenous ketamine

Objective: Conventional antidepressants take two weeks before their therapeutic action begins. Recent studies have reported on the rapid antidepressant effect of ketamine when given as an intravenous (I.V.) infusion. Little is known about its intramuscular (I.M.) use in depression. Hence this study...

Full description

Bibliographic Details
Main Authors:	Harihar Chilukuri, Narasimha Pothula Reddy, Ram Mohan Pathapati, Arkalgud Nagesha Manu, Sharada Jollu, Ahammad Basha Shaik
Format:	Article
Language:	English
Published:	SAGE Publishing 2014-01-01
Series:	Indian Journal of Psychological Medicine
Subjects:	Acute antidepressant effects antidepressant drugs depression intramuscular ketamine intravenous ketamine suicidal risk
Online Access:	http://www.ijpm.info/article.asp?issn=0253-7176;year=2014;volume=36;issue=1;spage=71;epage=76;aulast=Chilukuri

Similar Items

The Ketamine Antidepressant Story: New Insights
by: Tahani K. Alshammari
Published: (2020-12-01)

A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
by: Mohammad Gharavifard, et al.
Published: (2015-05-01)

Comparison between intravenous and intramuscular administration of ketamine in children sedation referred to emergency department
by: Behnaz Boroumand Rezazadeh, et al.
Published: (2014-12-01)

Low Doses of Ketamine and Melatonin in Combination Produce Additive Antidepressant-like Effects in Mice
by: Rosa Estrada-Reyes, et al.
Published: (2021-08-01)

Immunoregulation and antidepressant effect of ketamine
by: Zhang Nan, et al.
Published: (2021-05-01)

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
by: Caroline Ann Browne, et al.
Published: (2013-12-01)

Antidepressant Effect of Ketamine in Sub Anaesthetic Doses in Male Albino Mice
by: Lourdu Jafrin Antony, et al.
Published: (2014-06-01)

Ketamine may block NMDA receptors in astrocytescausing a rapid antidepressant effect
by: Bernhard J Mitterauer
Published: (2012-12-01)

Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine
by: Ming-Fen Ho, et al.
Published: (2019-11-01)

Mania following ketamine abuse
by: Lu YY, et al.
Published: (2016-01-01)

Controversies of the effect of ketamine on cognition
by: Melvyn WB Zhang, et al.
Published: (2016-03-01)

The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
by: Veronika Andrashko, et al.
Published: (2020-08-01)

Subcutaneous Ketamine in Depression: A Systematic Review
by: Vitor Breseghello Cavenaghi, et al.
Published: (2021-05-01)

A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
by: Mohammad Gharavifard, et al.
Published: (2018-12-01)

Rapid resolution of grief with IV infusion of ketamine: a unique phenomenological experience
by: Mahesh Ramanna Gowda, et al.
Published: (2016-01-01)

The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
by: Carlos A. Zarate Jr., et al.
Published: (2010-01-01)

Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine’s Rapid Antidepressant Actions
by: Lauren Wegman-Points, et al.
Published: (2020-11-01)

A Multiscale View of the Mechanisms Underlying Ketamine’s Antidepressant Effects: An Update on Neuronal Calcium Signaling
by: Ayako Kawatake-Kuno, et al.
Published: (2021-09-01)

Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade
by: Elena eNosyreva, et al.
Published: (2014-12-01)

Onset and Effect Duration of Intrabuccal Space and Intramuscular Ketamine in Pediatrics
by: Saeed Majidi, et al.
Published: (2018-01-01)

Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit—a mechanism of relevance to resistant depression?
by: Jing J. Wong, et al.
Published: (2016-02-01)

Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
by: Kenji Hashimoto
Published: (2015-04-01)

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
by: Acevedo-Diaz, E.E, et al.
Published: (2022)

Ketamine Produces a Long-Lasting Enhancement of CA1 Neuron Excitability
by: Grace Jang, et al.
Published: (2021-07-01)

Where ketamine and dopamine collide
by: David J Marcus, et al.
Published: (2021-06-01)

Ketamine for treatment-resistant depression : Moving away from conventional antidepressants
by: Blom, Emma-Clara
Published: (2021)

Intramuscular ketamine in acute depression: A case report
by: C Harihar
Published: (2011-01-01)

Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression
by: Lily R. Aleksandrova, et al.
Published: (2020-06-01)

The Antidepressant-Like Effects of a Clinically Relevant Dose of Ketamine Are Accompanied by Biphasic Alterations in Working Memory in the Wistar Kyoto Rat Model of Depression
by: Conor W. McDonnell, et al.
Published: (2021-01-01)

Extrasynaptic CaMKIIα is involved in the antidepressant effects of ketamine by downregulating GluN2B receptors in an LPS-induced depression model
by: Xiao-Hui Tang, et al.
Published: (2020-06-01)

Ketamine Rescues Hippocampal Reelin Expression and Synaptic Markers in the Repeated-Corticosterone Chronic Stress Paradigm
by: Jenessa N. Johnston, et al.
Published: (2020-09-01)

Determination of Diffusion Kinetics of Ketamine in Brain Tissue: Implications for in vitro Mechanistic Studies of Drug Actions
by: Zachary Geiger, et al.
Published: (2021-07-01)

Can Intraoperative Low-Dose R,S-Ketamine Prevent Depressive Symptoms After Surgery? The First Meta-Analysis of Clinical Trials
by: Liwei Pang, et al.
Published: (2020-10-01)

Fluoxetine and Ketamine Reverse the Depressive but Not Anxiety Behavior Induced by Lesion of Cholinergic Neurons in the Horizontal Limb of the Diagonal Band of Broca in Male Rat
by: Linghong Chen, et al.
Published: (2021-02-01)

Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus
by: Michael A. Pizzi, et al.
Published: (2017-08-01)

High-Speed Imaging Reveals Opposing Effects of Chronic Stress and Antidepressants on Neuronal Activity Propagation through the Hippocampal Trisynaptic Circuit
by: Jens eStepan, et al.
Published: (2015-11-01)

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
by: Duncan Jr WC, et al.
Published: (2018-10-01)

Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
by: Melodi A. Bowman, et al.
Published: (2020-10-01)

Comparison of quality of induction of anaesthesia between intramuscularly administered ketamine, intravenously administered ketamine and intravenously administered propofol in xylazine premedicated cats
by: T.B. Dzikiti, et al.
Published: (2007-06-01)

S-Ketamine Mediates Its Acute and Sustained Antidepressant-Like Activity through a 5-HT1B Receptor Dependent Mechanism in a Genetic Rat Model of Depression
by: Kristian G. du Jardin, et al.
Published: (2018-01-01)